Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

41.03 USD +0.08 (+0.20%)
Official Closing Price Updated: 4:42 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,633,200
Open 41.17
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 40.95
Today's Range 40.81 - 41.21
52wk Range 35.04 - 47.15
Shares Outstanding 6,830,797,784
Dividend Yield 2.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
Roche Obtains Exclusive Right to Develop and Distribute AT-527 Outside the United States 
From GlobeNewswire News Releases
Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of Venclexta® (venetoclax) in combination... 
From Business Wire News Releases

Performance

YTD
+0.34%
+0.34%
1 Month
-8.54%
-8.54%
3 Month
-4.47%
-4.47%
6 Month
-8.94%
-8.94%
1 Year
+11.80%
+11.80%

More News

Read More
Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
From Business Wire News Releases
Judge Rules Tamiflu-Maker Hoffman-La Roche Must Answer Whistleblower Fraud Claims
From PR Newswire
Solving One of the Largest Drivers of Disease: Inflammation
From PR Newswire
NetworkNewsAudio – 180 Life Sciences Corp. Dedicated to Developing Groundbreaking Anti-Inflammatory Drugs
From InvestorBrandNetwork
Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
Tags REGN Jeremy Levin EYLEA
From Benzinga
Solving One of the Largest Drivers of Disease: Inflammation
From InvestorBrandNetwork
IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
Tags Eargo IONS Opthea Limited
From Benzinga
Opthea IPO: What Investors Should Know About The Genentech, Regeneron Challenger
Tags Healthcare
From Blogs - TalkMarkets
IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week
Tags Stocks / Equities Pharma/Biotech Energy
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.